MRX003 is a generic capsule based inhaler designed in particular as a generic AB rated device for tiotropium DPI. It is developed for new molecules and the life cycle management of inhaled therapies. In February 2017, MRX003, was given the nod by the FDA as a suitable generic device with which to ...See more
Headquarters:
Australia
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2017 (8 years)
Address:
null
LOW
spending power
